Is Board Appointment Altering The Investment Case For Amplitude (AMPL)?
INGM or AMPL: Which Is the Better Value Stock Right Now?
BTIG Maintains Buy on Amplitude, Raises Price Target to $17
3 Reasons to Sell AMPL and 1 Stock to Buy Instead
Amplitude Appoints Statsig Founder Vijaye Raji to Board of Directors
B of A Securities Maintains Neutral on Amplitude, Raises Price Target to $16.5
Amplitude (AMPL) Could Be 14% Above Fair Value On Its AI And Enterprise Push
INGM vs. AMPL: Which Stock Is the Better Value Option?
Q2 Earnings Roundup: Amplitude (NASDAQ:AMPL) And The Rest Of The Data Analytics Segment
Piper Sandler Maintains Overweight on Amplitude, Raises Price Target to $18
Full Transcript: Amplitude Q2 2026 Earnings Call
AMADY vs. AMPL: Which Stock Is the Better Value Option?
Amplitude: The Rebound Rally Is Here, Fueled By Impressive Backlog Growth
Amplitude, Inc. (AMPL) Presents at Citi's 2026 Global TMT Conference Prepared Remarks Transcript
Amplitude (AMPL) Dropped, So What Is Driving Attention Now?
Amplitude (AMPL) Stock May Be 44% Undervalued On Cash Flow Questions
Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases
The Top 5 Analyst Questions From Amplitude’s Q2 Earnings Call
Morgan Stanley Maintains Overweight on Amplitude, Raises Price Target to $16
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.